Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Targeted therapies are the focus of much research in oncology. Encouraging results from the development of new monoclonal antibodies are revolutionizing clinical therapies and this is particularly the case for haematologic malignancies. The advent of immunotherapy heralds a new era particularly for patients who are refractory to more traditional therapies. Impressive results are evident using monoclonal antibodies (mAb) that a) bind with high specificity to cell-surface antigens, resulting in targeted killing of the malignant cells or b) are conjugated to radioisotopes, toxins, enzymes or drug

Cancer. --- Lymphatics. --- Lymphoma. --- Lymphoma --- Immunotherapy --- Lymphoproliferative Disorders --- Neoplasms by Histologic Type --- Immunomodulation --- Lymphatic Diseases --- Biological Therapy --- Immunoproliferative Disorders --- Neoplasms --- Immune System Diseases --- Diseases --- Therapeutics --- Hemic and Lymphatic Diseases --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Diseases of Immune System --- Immune Diseases --- Immunological Diseases --- Immune Disorders --- Immunologic Diseases --- Disease, Immune --- Disease, Immune System --- Disease, Immunologic --- Disease, Immunological --- Diseases, Immune --- Diseases, Immune System --- Diseases, Immunologic --- Diseases, Immunological --- Disorder, Immune --- Disorders, Immune --- Immune Disease --- Immune Disorder --- Immune System Disease --- Immunologic Disease --- Immunological Disease --- Therapy --- Treatment --- Therapeutic --- Therapies --- Treatments --- Disease --- Benign Neoplasms --- Malignancy --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Cancer --- Tumors --- Benign Neoplasm --- Cancers --- Malignancies --- Neoplasias --- Neoplasm, Benign --- Tumor --- Germinoblastoma --- Lymphoma, Malignant --- Reticulolymphosarcoma --- Sarcoma, Germinoblastic --- Germinoblastic Sarcoma --- Germinoblastic Sarcomas --- Germinoblastomas --- Lymphomas --- Lymphomas, Malignant --- Malignant Lymphoma --- Malignant Lymphomas --- Reticulolymphosarcomas --- Sarcomas, Germinoblastic --- Disorder, Immunoproliferative --- Disorders, Immunoproliferative --- Immunoproliferative Disorder --- Biologic Therapy --- Biotherapy --- Therapy, Biological --- Biologic Therapies --- Biological Therapies --- Biotherapies --- Therapies, Biologic --- Therapies, Biological --- Therapy, Biologic --- Lymphatism --- Status Lymphaticus --- Disease, Lymphatic --- Diseases, Lymphatic --- Lymphatic Disease --- Immunomodulatory Therapy --- Immunomodulations --- Immunomodulatory Therapies --- Therapies, Immunomodulatory --- Therapy, Immunomodulatory --- Histological Type of Neoplasm --- Histological Types of Neoplasms --- Neoplasms by Histological Type --- Neoplasm Histological Type --- Neoplasm Histological Types --- Neoplasms Histological Type --- Neoplasms Histological Types --- Duncan Disease --- Epstein-Barr Virus Infection, Familial Fatal --- Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males --- Familial Fatal Epstein-Barr Infection --- Immunodeficiency 5 --- Immunodeficiency, X-Linked Progressive Combined Variable --- Lymphoproliferative Disease, X-Linked --- Lymphoproliferative Syndrome, X-Linked, 1 --- Purtilo Syndrome --- X-Linked Lymphoproliferative Disease --- X-Linked Lymphoproliferative Disorder --- Duncan's Syndrome --- X-Linked Lymphoproliferative Syndrome --- Disease, Duncan --- Disease, X-Linked Lymphoproliferative --- Diseases, X-Linked Lymphoproliferative --- Disorder, Lymphoproliferative --- Disorder, X-Linked Lymphoproliferative --- Disorders, Lymphoproliferative --- Disorders, X-Linked Lymphoproliferative --- Epstein Barr Virus Induced Lymphoproliferative Disease In Males --- Epstein Barr Virus Infection, Familial Fatal --- Familial Fatal Epstein Barr Infection --- Immunodeficiency 5s --- Immunodeficiency, X Linked Progressive Combined Variable --- Lymphoproliferative Disease, X Linked --- Lymphoproliferative Diseases, X-Linked --- Lymphoproliferative Disorder --- Lymphoproliferative Disorder, X-Linked --- Lymphoproliferative Disorders, X-Linked --- Lymphoproliferative Syndrome, X-Linked --- Lymphoproliferative Syndromes, X-Linked --- Purtilo Syndromes --- Syndrome, Purtilo --- Syndrome, X-Linked Lymphoproliferative --- Syndromes, Purtilo --- Syndromes, X-Linked Lymphoproliferative --- X Linked Lymphoproliferative Disease --- X Linked Lymphoproliferative Disorder --- X Linked Lymphoproliferative Syndrome --- X-Linked Lymphoproliferative Diseases --- X-Linked Lymphoproliferative Disorders --- X-Linked Lymphoproliferative Syndromes --- Immunotherapies --- therapy --- Malignant Neoplasms --- Malignant Neoplasm --- Neoplasm, Malignant --- Neoplasms, Malignant --- Medical Oncology --- Hematologic Neoplasms --- Amyloidosis --- Immunity, Active --- Immunologic Techniques --- Immune System Disorders --- Disorder, Immune System --- Immune System Disorder --- Blood and Lymphatic System Disorders --- Combined Antibody Therapeutics --- Diagnostic Techniques and Procedures